We conclude that the interpretation of noncoding mutations can be improved by focusing on TF-DNA interactions with the combined analysis of both transcriptional and post-transcriptional regulation of gene expression to revert the paucity in the discovery of cancer-associated noncoding events. The gene discussed is TF; the disease is cancer.